Blue Fin Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.11M Buy
20,919
+130
+0.6% +$30.3K 0.84% 24
2025
Q4
$4.3M Buy
20,789
+156
+0.8% +$30.8K 0.67% 32
2025
Q3
$3.83M Sell
20,633
-111
-0.5% -$19K 0.6% 33
2025
Q2
$3.17M Buy
20,744
+1,137
+6% +$175K 0.54% 36
2025
Q1
$3.25M Buy
19,607
+1,267
+7% +$198K 0.63% 33
2024
Q4
$2.65M Sell
18,340
-814
-4% -$126K 0.49% 39
2024
Q3
$3.1M Sell
19,154
-146
-0.8% -$23.3K 0.59% 37
2024
Q2
$2.82M Buy
19,300
+46
+0.2% +$6.84K 0.56% 38
2024
Q1
$3.05M Sell
19,254
-171
-0.9% -$27.2K 0.68% 34
2023
Q4
$3.04M Sell
19,425
-1,261
-6% -$193K 0.78% 30
2023
Q3
$3.22M Buy
20,686
+132
+0.6% +$21.8K 0.94% 23
2023
Q2
$3.4M Sell
20,554
-47
-0.2% -$7.59K 0.97% 24
2023
Q1
$3.34M Sell
20,601
-115
-0.6% -$18.6K 1.08% 22
2022
Q4
$3.66M Sell
20,716
-251
-1% -$43.3K 1.34% 18
2022
Q3
$3.42M Buy
20,967
+664
+3% +$112K 1.29% 18
2022
Q2
$3.6M Sell
20,303
-72
-0.4% -$12.8K 1.28% 17
2022
Q1
$3.61M Buy
20,375
+245
+1% +$41.7K 1.05% 23
2021
Q4
$3.44M Sell
20,130
-418
-2% -$68.4K 0.95% 29
2021
Q3
$3.32M Sell
20,548
-117
-0.6% -$20K 1.01% 27
2021
Q2
$3.4M Sell
20,665
-449
-2% -$74.3K 1.05% 25
2021
Q1
$3.47M Buy
21,114
+155
+0.7% +$25.1K 1.19% 22
2020
Q4
$3.3M Buy
20,959
+1,826
+10% +$269K 1.18% 21
2020
Q3
$2.85M Sell
19,133
-2,131
-10% -$315K 1.15% 21
2020
Q2
$2.99M Buy
21,264
+2,629
+14% +$383K 1.32% 17
2020
Q1
$2.44M Buy
18,635
+18
+0.1% +$2.55K 1.35% 17
2019
Q4
$2.71M Sell
18,617
-182
-1% -$24.7K 1.28% 19
2019
Q3
$2.43M Sell
18,799
-1,171
-6% -$154K 1.27% 20
2019
Q2
$2.78M Buy
19,970
+187
+0.9% +$25.9K 1.43% 16
2019
Q1
$2.77M Sell
19,783
-218
-1% -$29.2K 1.45% 16
2018
Q4
$2.58M Sell
20,001
-467
-2% -$65.1K 1.54% 16
2018
Q3
$2.83M Sell
20,468
-31
-0.2% -$4.12K 1.4% 18
2018
Q2
$2.49M Sell
20,499
-185
-0.9% -$23.1K 1.33% 19
2018
Q1
$2.65M Buy
20,684
+910
+5% +$123K 1.5% 17
2017
Q4
$2.76M Sell
19,774
-31
-0.2% -$4.32K 1.61% 15
2017
Q3
$2.57M Buy
19,805
+460
+2% +$61K 1.58% 15
2017
Q2
$2.56M Sell
19,345
-2,685
-12% -$343K 1.65% 15
2017
Q1
$2.74M Sell
22,030
-645
-3% -$77.1K 1.68% 13
2016
Q4
$2.61M Buy
22,675
+4,134
+22% +$478K 1.73% 13
2016
Q3
$2.19M Sell
18,541
-904
-5% -$110K 1.78% 12
2016
Q2
$2.36M Buy
19,445
+32
+0.2% +$3.64K 1.96% 10
2016
Q1
$2.1M Sell
19,413
-1,965
-9% -$203K 1.79% 12
2015
Q4
$2.2M Sell
21,378
-425
-2% -$42.7K 1.69% 14
2015
Q3
$2.04M Buy
21,803
+325
+2% +$31.4K 1.58% 16
2015
Q2
$2.09M Sell
21,478
-100
-0.5% -$10K 1.51% 16
2015
Q1
$2.17M Buy
21,578
+550
+3% +$55.9K 1.57% 14
2014
Q4
$2.2M Sell
21,028
-30
-0.1% -$3.16K 1.66% 12
2014
Q3
$2.25M Buy
21,058
+95
+0.5% +$9.85K 1.78% 11
2014
Q2
$2.19M Sell
20,963
-450
-2% -$45.5K 1.76% 12
2014
Q1
$2.1M Sell
21,413
-407
-2% -$37.7K 1.85% 11
2013
Q4
$2M Buy
+21,820
New +$2.01M 1.78% 11

Other funds holding JNJ

Blue Fin Capital's JNJ Position: Q1 2026 in Review

Blue Fin Capital increased its Johnson & Johnson (JNJ) stake by 0.63% in Q1 2026, buying an estimated $30.3K and bringing the position to 20,919 shares worth $5.11M. The position accounts for 0.84% of the portfolio, ranked #24.

Blue Fin Capital first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Blue Fin Capital held 20,919 shares of Johnson & Johnson worth $5.11M as of Q1 2026.
  • Blue Fin Capital bought 130 Johnson & Johnson shares in Q1 2026, an estimated $30.3K.
  • Johnson & Johnson made up 0.84% of Blue Fin Capital's portfolio in Q1 2026, its #24 holding.
  • Blue Fin Capital first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Blue Fin Capital's 13F filing for Q1 2026, filed 28 May 2026.